NCT06037902 CPAP for Esophageal Cancer With Radiotherapy
| NCT ID | NCT06037902 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sheba Medical Center |
| Condition | Esophageal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2023-08-21 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2023-08-21 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test the use of CPAP in patients with esophgaeal cancer undergoing radiotherapy. The main questions it aims to answer are: * does use of CPAP decrease exposure of normal lung to radiation? * does use of CPAP decrease exposure of normal heart to radiation? Participants will undergo simulation twice: * with CPAP * without CPAP
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of cancer, with a tumor (primary or secondary) in the esophagus including tumors in the esophagus-stomach junction. 2. Age ≥ 18 3. Planned RT treatment 4. The level of functioning ≥ 60 on the Karnofsky scale 5. Life expectancy ≥ two months 6. All patients must understand the informed consent form document and sign it of their own free will before any test/procedure related to the study is performed. 7. Able to undergo simulation and radiation with CPAP 8. Candidate patients can be recruited to receive definitive, palliative or pre-operative radiation, with or without chemotherapy. Exclusion Criteria: A person who meets any of the following exclusion criteria will not be able to participate in the study: 1. Pregnancy or breastfeeding 2. Significant comorbidity at the starting point that would prevent the use of CPAP 3. Hospitalized in an institution by virtue of an administrative order or a court order. 4. Special population 5. A history of a psychiatric problem that may impair the patient's ability to understand the research requirements or respond to them, or to give his consent
Frequently Asked Questions
Who can join the NCT06037902 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06037902 currently recruiting?
Yes, NCT06037902 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sheba Medical Center to inquire about joining.
Where is the NCT06037902 trial being conducted?
This trial is being conducted at Ramat Gan, Israel.
Who is sponsoring the NCT06037902 clinical trial?
NCT06037902 is sponsored by Sheba Medical Center. The trial plans to enroll 44 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.